Verrica Pharmaceuticals (VRCA) Other Accumulated Expenses (2017 - 2026)
Verrica Pharmaceuticals' Other Accumulated Expenses came in at $4 million for Q2 2026, up 992.9% from $366,000 a year earlier.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2024, Verrica Pharmaceuticals' Other Accumulated Expenses was $105,000, down 57.0% from FY2023.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 40.8% (FY2019 to FY2024).
- Going back by year, Other Accumulated Expenses was $244,000 in FY2023, $250,000 in FY2021 (+14.2%) and $219,000 in FY2020.
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2017.
- Year-over-year, Other Accumulated Expenses increased in three of the last five quarters, with growth averaging 192.2%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2026 (growth of 992.9%), and the weakest in Q4 2024 (a decline of 57.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Verrica Pharmaceuticals | 75.24 Mn | -7.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Jun 30, 2025 | 366,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2022 | 242,000.00 |
| Mar 31, 2022 | 219,000.00 |
| Dec 31, 2021 | 250,000.00 |
| Sep 30, 2021 | 242,000.00 |
| Jun 30, 2021 | 242,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Dec 31, 2020 | 219,000.00 |
| Sep 30, 2020 | 211,000.00 |
| Jun 30, 2020 | 211,000.00 |
| Mar 31, 2020 | 155,000.00 |
| Dec 31, 2019 | 19,000.00 |
API Access
Verrica Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();